DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20190487

A comparative study of lipid profile in patients with and without infective hepatitis

Hemlatha D. Naik, Chandrashekar V. Kubihal

Abstract


Background: Liver plays a central role in lipid metabolism. Liver carries out some important functions in lipid metabolism like liver facilitates the digestion and absorption of lipids by the production of bile, which contains cholesterol and bile salts synthesized within the liver de novo or from uptake of lipoprotein cholesterol, the liver has active enzyme system for synthesizing and oxidizing fatty acids and for synthesizing triacylglycerols and phospholipids, synthesis of the ketone bodies, it plays an integral part in the synthesis and metabolism of plasma lipoproteins. The objective was to compare lipid profile in patients with and without infective hepatitis.

Methods: Hospital based cross sectional comparative study was carried out among 112 cases. The patients were divided as having infective hepatitis (69) called cases and not having infective hepatitis (43) called controls. Concentration of serum total cholesterol was determined by Carr and Drekter method. Concentration of serum HDL cholesterol was determined by Carr and Drekter method. Concentration of serum triglyceride level was determined by enzymatic end point peroxidase coupled method.

Results: Total cholesterol, VLDL, LDL and triglycerides have been found to be significantly higher in cases of infective hepatitis compared to control. The HDL value was also significantly deranged i.e. significantly lower in cases compared to controls (p <0.05). Thus, it was clear that infective hepatitis deranges the lipid profile of the patients.

Conclusions: Lipid profile can be used as sensitive indicators of hepatic function and may have diagnostic and prognostic importance in infective hepatitis.


Keywords


Comparison, Controls, Cases, Infective hepatitis, Lipid profile

Full Text:

PDF

References


Corless JK, Middleton HM. Normal liver function: A Basis for Understanding Hepatic Disease. Arch Int Med. 1983;143:2291-4.

Mukherjee S, Kunitake G, Alfin-Slater RB. The esterification of cholesterol with palmitic acid by rat liver homogenates. J Biol Chem. 1958;230(1):91-6.

Pierce JF, Kimmel JR, Burns TW. Lipoproteins in infectious and serum hepatitis. Metab: Clin Experimental. 1954;3(3):228-39.

Friedman M, Byers SO. Observations concerning the production and excretion of cholesterol in mammals. XVI. The relationship of the liver to the content and control of plasma cholesterol ester. J Clin Investigation. 1955;34(9):1369-74.

Tietz NW. Fundamentals of Clinical Chemistry. 1st ed. 1970: 356-7.

Brutis CA, Ashwood ER. Tietz Textbook of Clinical Chemistry, 2nd ed. 1994: 1073-1075.

Flint AU. Art I. Experimental researches into a new excretory function of the liver; consisting in the removal of cholesterine from the blood, and its discharge from the body in the form of stercorine. Am J Med Sci (1827-1924). 1862;(88):305.

Epstein EZ. Cholesterol of the blood plasma in hepatic and biliary diseases. Arch Inter Med. 1932;50(2):203-22.

Man EB, Kartin BL, Durlacher SH, Peters JP. The lipids of serum and liver in patients with hepatic diseases. J Clin Investigation. 1945;24(5):623-43.

Mendenhall CL, Mortiaux A. Alterations in serum triglyceride levels in liver disease. Gastroenterol. 1962;42(6):684-5.

Gallin JI, Kaye D, O'Leary WM. Serum lipids in infection. New Eng J Med. 1969;281(20):1081-6.

Tamir I, Heldenberg D, Levtow O, Burstein Y, Lupo S, Werbin B. Behaviour of serum lipids in children with hepatitis A. Inter J Clin Chem. 1974;56(1):113-20.

Mcintyre NE. Plasma lipids and lipoproteins in liver disease. Gut. 1978;19(6):526-30.

Papadopoulos NM, Charles MA. Serum lipoprotein patterns in liver disease. Proceedings Soc Experimental Biol Med. 1970;134(3):797-9.

Vergani C, Trovato G, Delu A, Pietrogrande M, Dioguardi N. Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease. J Clin Pathol. 1978;31(8):772-8.

Goel VK, Mehrotra TN, Srivastava SS, Singh VS, Gupta V. Observation of lipid profile and lipoproteins in viral hepatitis and hepatic coma. J Assoc Physicians India. 1993;41(10):651-2.

Albrink MJ, Man EB, Peters JP. Serum lipids in infectious hepatitis and obstructive jaundice. J Clin Investigation. 1950;29(6):781-8.

Yamamoto K. LCAT Activity, apolipoprotein AL and Lipoprotein-X in the parenchymal and cholestatic liver diseases (author's transl). Fukuoka igaku zasshi= Hukuoka Med. 1980;71(10):574.